Sinigrin improves cerebral ischaemia‐reperfusion injury by inhibiting the TLR4 pathway‐mediated oxidative stress

Shenglong Guo,Qi Lei,Qian Yang,Ruili Chen
DOI: https://doi.org/10.1111/cbdd.14480
2024-02-20
Chemical Biology & Drug Design
Abstract:Sinigrin Protects the Brain from CIR Injury by Reducing Oxidative Stress and Inhibiting the TLR4 Signaling Pathway. Cerebral ischaemia‐reperfusion (CIR) injury occurs in stroke patients after the restoration of cerebral perfusion. Sinigrin, a phytochemical found in cruciferous vegetables, exhibits strong antioxidant activity. This study investigated the role of sinigrin in oxidative stress using a CIR injury model. The effects of sinigrin were studied in middle cerebral artery occlusion (MCAO) rats and oxygen–glucose deprivation/reoxygenation (OGD/R)‐injured SH‐SY5Y cells. Sinigrin treatment improved brain injury and neurological deficits induced by MCAO surgery in rats. Sinigrin inhibited apoptosis in brain tissues and SH‐SY5Y cells following OGD/R induction. Additionally, sinigrin elevated the levels of superoxide dismutase (SOD), glutathione (GSH) and glutathione peroxidase (GSH‐Px) while reducing malondialdehyde (MDA) levels. Furthermore, sinigrin inhibited the toll‐like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signalling pathway. The anti‐apoptotic and antioxidant activities of sinigrin in OGD/R‐injured SH‐SY5Y cells were reversed by TLR4 overexpression. In conclusion, sinigrin inhibits oxidative stress in CIR injury by suppressing the TLR4/MyD88 signalling pathway.
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?